FUROSEMIDE 10 Mg/Ml Solution for Injection アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

furosemide 10 mg/ml solution for injection

claris lifesciences (uk) limited - furosemide - solution for injection - 10 mg/ml - sulfonamides, plain

ACICLOVIR CLARIS 25 Mg/Ml Concentrate for Soln for Inf アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

aciclovir claris 25 mg/ml concentrate for soln for inf

claris lifesciences (uk) limited - aciclovir - concentrate for soln for inf - 25 mg/ml - nucleosides and nucleotides excl. reverse transcriptase inhibitors

ADENOSINE BAXTER adenosine 30 mg/10 mL solution for infusion vial オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

adenosine baxter adenosine 30 mg/10 ml solution for infusion vial

baxter healthcare pty ltd - adenosine, quantity: 30 mg - solution - excipient ingredients: sodium chloride; water for injections - intravenous adenosine (30 mg/10 ml) is a coronary vasodilator for use in conjunction with radionuclide myocardial perfusion imaging, in patients unable to exercise adequately.

Metronidazole-Claris ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

metronidazole-claris

baxter healthcare ltd - metronidazole 5 mg/ml - solution for infusion - 500 mg/100ml - active: metronidazole 5 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate sodium chloride water for injection - metronidazole-claris intravenous infusion is indicated: · for treatment of anaerobic infections in patients for whom oral administration is not possible. · when immediate anti-anaerobic therapy is required. · when prophylactic cover is required at lower abdominal surgical sites presumed contaminated or potentially contaminated by anaerobic micro-organisms. procedures of this type include appendicectomy, colonic surgery, vaginal hysterectomy, abdominal surgery in the presence of anaerobes in the peritoneal cavity and surgery performed in the presence of anaerobic septicaemia. note: metronidazole is inactive against aerobic or facultative anaerobic bacteria.

RANITIDINE CLARIS アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

ranitidine claris

claris lifesciences (uk) limited - ranitidine hydrochloride - solution for inj/inf - 25 base mg/ml

RANITIDINE CLARIS 25 Base mg/ml Solution for Inj/Inf アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

ranitidine claris 25 base mg/ml solution for inj/inf

claris lifesciences (uk) limited - ranitidine hydrochloride - solution for inj/inf - 25 base mg/ml

Clariscan 279.32 mg/ml solution for injection アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

clariscan 279.32 mg/ml solution for injection

ge healthcare as - gadoteric acid - solution for injection - 279.3 milligram(s)/millilitre - paramagnetic contrast media; gadoteric acid

Clariscan 279.32 mg/ml solution for injection in pre-filled syringe アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

clariscan 279.32 mg/ml solution for injection in pre-filled syringe

ge healthcare as - gadoteric acid - solution for injection in pre-filled syringe - 279.3 milligram(s)/millilitre - paramagnetic contrast media; gadoteric acid

Clariscan 0.5mmol/ml, Solution for injection マルタ - 英語 - Medicines Authority

clariscan 0.5mmol/ml, solution for injection

ge healthcare as nycoveien 1, no-0485 oslo, norway - gadoteric acid - solution for injection - gadoteric acid 279.3 mg - contrast media

Clariscan 0.5mmol/ml, Solution for injection in pre-filled syringe マルタ - 英語 - Medicines Authority

clariscan 0.5mmol/ml, solution for injection in pre-filled syringe

ge healthcare as nycoveien 1, no-0485 oslo, norway - gadoteric acid - solution for injection - gadoteric acid 279.3 mg - contrast media